Company Profile · Healthcare

Shijiazhuang Yiling Pharmaceutical Co Ltd

002603 · Shenzhen

Country: China
IPO date: Jul 28, 2011
Employees: 11,343
Website: www.yiling.cn

Buffett Score

34/100

Poor

Financial snapshot

Market capCN¥25.65B

Revenue (TTM)CN¥7.87B

EBITDACN¥2.31B

Profit margin17.49%

ROE12.62%

P/E (TTM)18.72

Forward P/E58.48

PEG0

EPSCN¥0.82

Dividend yield3.33%

52-week rangeCN¥14.22 – CN¥20.90

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

About the company

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and personal protective equipment products; and TCM formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Background

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

Research on this stock

No reports on this stock in your language yet.